Literature DB >> 21968272

Correlation of synovial fluid HMGB-1 levels with radiographic severity of knee osteoarthritis.

Zhan-Chun Li1, Guang-Qi Cheng, Kong-Zu Hu, Mao-Qiang Li, Wei-Ping Zang, Yu-Qi Dong, Wei-Li Wang, Zu-De Liu.   

Abstract

PURPOSE: This study measured high-mobility group box 1 (HMGB-1) levels in serum and synovial fluid (SF) in patients with primary knee osteoarthritis (OA) and correlated these levels with radiographic disease severity.
METHODS: Seventy-eight OA patients and 30 controls were enrolled in this study. All OA patients were scored according to the Kellgren-Lawrence (KL) grading system. HMGB-1 levels were measured by enzyme-linked immunosorbent assay (ELISA).
RESULTS: SF HMGB-1 levels were significantly higher in knee OA patients, compared with controls (P < 0.01). Moreover, SF HMGB-1 levels were positively associated with KL scores (P < 0.01). Multinomial logistic regression demonstrated that the SF HMGB-1 level was an independent factor for radiographic severity of OA (P=0.002); however, serum HMGB-1 levels did not differ significantly between OA patients and controls and did not correlate with KL scores (P > 0.05).
CONCLUSION: These results demonstrate that HMGB-1 levels in SF of knee OA patients are independently associated with radiographic disease severity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21968272     DOI: 10.25011/cim.v34i5.15673

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  12 in total

Review 1.  The danger from within: alarmins in arthritis.

Authors:  Meriam Nefla; Dirk Holzinger; Francis Berenbaum; Claire Jacques
Journal:  Nat Rev Rheumatol       Date:  2016-10-13       Impact factor: 20.543

Review 2.  HMGB proteins and arthritis.

Authors:  Noboru Taniguchi; Yasuhiko Kawakami; Ikuro Maruyama; Martin Lotz
Journal:  Hum Cell       Date:  2017-09-15       Impact factor: 4.174

Review 3.  Inflammation in osteoarthritis: is it time to dampen the alarm(in) in this debilitating disease?

Authors:  M H J van den Bosch
Journal:  Clin Exp Immunol       Date:  2018-11-28       Impact factor: 4.330

Review 4.  Synovial inflammation in osteoarthritis progression.

Authors:  Elsa Sanchez-Lopez; Roxana Coras; Alyssa Torres; Nancy E Lane; Monica Guma
Journal:  Nat Rev Rheumatol       Date:  2022-02-14       Impact factor: 32.286

5.  MicroRNA-142-3p Inhibits Chondrocyte Apoptosis and Inflammation in Osteoarthritis by Targeting HMGB1.

Authors:  Xiuqin Wang; Yanqing Guo; Chunyan Wang; Hong Yu; Xiuxiang Yu; Hongbo Yu
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

6.  Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations.

Authors:  Jeremy Sokolove; Christin M Lepus
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-04       Impact factor: 5.346

7.  Glycyrrhizin, an HMGB1 inhibitor, Suppresses Interleukin-1β-Induced Inflammatory Responses in Chondrocytes from Patients with Osteoarthritis.

Authors:  Shifeng Zhou; Guodan Liu; Zhenxing Si; Luanfei Yu; Limin Hou
Journal:  Cartilage       Date:  2020-06-30       Impact factor: 3.117

8.  MicroRNA-410-3p modulates chondrocyte apoptosis and inflammation by targeting high mobility group box 1 (HMGB1) in an osteoarthritis mouse model.

Authors:  Hong Pan; Huming Dai; Linzhi Wang; Silong Lin; Yuefeng Tao; Yi Zheng; Renyi Jiang; Fan Fang; Yifan Wu
Journal:  BMC Musculoskelet Disord       Date:  2020-07-24       Impact factor: 2.362

Review 9.  The Importance of the Knee Joint Meniscal Fibrocartilages as Stabilizing Weight Bearing Structures Providing Global Protection to Human Knee-Joint Tissues.

Authors:  James Melrose
Journal:  Cells       Date:  2019-04-06       Impact factor: 6.600

Review 10.  Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults.

Authors:  John Eppensteiner; Robert Patrick Davis; Andrew S Barbas; Jean Kwun; Jaewoo Lee
Journal:  Front Immunol       Date:  2018-02-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.